Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization

PLoS Pathogens

Volumn 9, Issue 1, 2013, Pages

  Leibovitch, Emily ^a,b   Wohler, Jillian E ^a   Cummings Macri, Sheila M ^c   Motanic, Kelsey ^a   Harberts, Erin ^a   Gaitán, María I ^a   Maggi, Pietro ^a   Ellis, Mary ^c   Westmoreland, Susan ^c   Silva, Afonso ^a   Reich, Daniel S ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ATAXIA; CALLITHRIX; CALLITRICHINAE; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; FEMALE; HEMIPLEGIA; HISTOPATHOLOGY; HUMAN HERPESVIRUS 6; IMMUNOHISTOCHEMISTRY; INOCULATION; MALE; MYELIN SHEATH; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; POLYMERASE CHAIN REACTION; RECTUM TEMPERATURE; VIRUS INFECTION;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; CALLITHRIX; DISEASE MODELS, ANIMAL; DNA, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; ROSEOLOVIRUS INFECTIONS; SPINAL CORD;

EID: 84875058324     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003138     Document Type: Article

References (64)

1. Pellett PE, Dominguez G. (2001) Chapter 80. Human Herpesviruses 6A, 6B, and 7 and Their Replication. In: Knipe DM, Howley, P.M., editor. Fields Virology. 4th edition. Philadelphia: Lippincott, Williams & Wilkins. pp. 69-2784.
2. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, et al. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596-601.
3. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, et al. (1999) Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73: 8040-8052.
4. De Bolle L, Naesens L, De Clercq E, (2005) Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18: 217-245.
5. De Bolle L, Van Loon J, De Clercq E, Naesens L, (2005) Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 75: 76-85.
6. Dewhurst S, Skrincosky D, van Loon N, (1997) Human herpesvirus 6. Expert Rev Mol Med 1997: 1-17.
7. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, et al. (2005) A population-based study of primary human herpesvirus 6 infection. New England Journal of Medicine 352: 768-776.
8. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, et al. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065-1067.
9. Braun DK, Dominguez G, Pellett PE, (1997) Human herpesvirus 6. Clinical Microbiology Reviews 10: 521-567.
10. Clark DA, (2000) Human herpesvirus 6. Rev Med Virol 10: 155-173.
11. Krueger GR, Ablashi DV, (2003) Human herpesvirus-6: a short review of its biological behavior. Intervirology 46: 257-269.
12. Luppi M, Marasca R, Barozzi P, Ferrari S, Ceccherini-Nelli L, et al. (1993) Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. J Med Virol 40: 44-52.
13. Yoshikawa T, Ihira M, Suzuki K, Suga S, Iida K, et al. (2000) Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 62: 52-59.
14. Shintaku M, Kaneda D, Tada K, Katano H, Sata T, (2010) Human herpes virus 6 encephalomyelitis after bone marrow transplantation: report of an autopsy case. Neuropathology 30: 50-55.
15. Lautenschlager I, Razonable RR, (2012) Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int 25: 493-502.
16. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, et al. (2001) Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 63: 45-51.
17. Yao K, Crawford JR, Komaroff AL, Ablashi DV, Jacobson S, (2010) Review part 2: Human herpesvirus-6 in central nervous system diseases. J Med Virol 82: 1669-1678.
18. Tavakoli NP, Nattanmai S, Hull R, Fusco H, Dzigua L, et al. (2007) Detection and typing of human herpes virus 6 by molecular methods, in specimens from patients diagnosed with encephalitis/meningitis. J Clin Microbiol 45: 3972-8.
19. Gewurz BE, Marty FM, Baden LR, Katz JT, (2008) Human herpesvirus 6 encephalitis. Current Infectious Disease Reports 10: 292-299.
20. Yao K, Honarmand S, Espinosa A, Akhyani N, Glaser C, et al. (2009) Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol 65: 257-267.
21. Uesugi H, Shimizu H, Maehara T, Arai N, Nakayama H, (2000) Presence of human herpesvirus 6 and herpes simplex virus detected by polymerase chain reaction in surgical tissue from temporal lobe epileptic patients. Psychiatry Clin Neurosci 54: 589-593.
22. Theodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, et al. (2008) Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49: 1828-1837.
23. Alvarez-Lafuente R, de Las Heras V, Bartolome M, Garcia-Montojo M, Arroyo R, (2006) Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol 16: 20-27.
24. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S, (2000) Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 47: 306-313.
25. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, et al. (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92: 7440-7444.
26. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM, (2003) Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 187: 1365-1376.
27. Opsahl ML, Kennedy PG, (2005) Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128: 516-527.
28. Cermelli C, Berti R, Soldan SS, Mayne M, D'Ambrosia JM, et al. (2003) High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187: 1377-1387.
29. Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, et al. (2000) Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182: 1321-1325.
30. Berti R, Brennan MB, Soldan SS, Ohayon JM, Casareto L, et al. (2002) Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 8: 250-256.
31. Khaki M, Ghazavi A, Ghasami K, Rafiei M, Payani MA, et al. (2011) Evaluation of viral antibodies in Iranian multiple sclerosis patients. Neurosciences (Riyadh) 16: 224-228.
32. Simpson S, Taylor B, Dwyer D, Taylor J, Blizzard L, et al. (2011) Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Multiple Sclerosis Journal 18: 799-806.
33. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, et al. (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA [see comments]. Nat Med 3: 1394-1397.
34. Fotheringham J, Donati D, Akhyani N, Fogdell-Hahn A, Vortmeyer A, et al. (2007) Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 4: e180.
35. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, et al. (1999) CD46 is a cellular receptor for human herpesvirus 6. Cell 99: 817-827.
36. Murakami Y, Seya T, Kurita M, Fukui A, Ueda S, et al. (1998) Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus. Biochem J 330 (Pt 3):: 1351-1359.
37. Okano H, Hikishima K, Iriki A, Sasaki E, (2012) The common marmoset as a novel animal model system for biomedical and neuroscience research applications. Seminars in Fetal & Neonatal Medicine pp. 1-5.
38. Uccelli A, Giunti D, Capello E, Roccatagliata L, Mancardi GL, (2003) EAE in the common marmoset Callithrix jacchus. Int MS J 10: 6-12.
39. t Hart BA, Massacesi L, (2009) Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J Neuropathol Exp Neurol 68: 341-355.
40. t Hart BA, Laman JD, Bauer J, Blezer E, van Kooyk Y, et al. (2004) Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol 3: 588-597.
41. Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, et al. (1995) Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 37: 519-530.
42. Provost PJ, Keller PM, Banker FS, Keech BJ, Klein HJ, et al. (1987) Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus. J Virol 61: 2951-2955.
43. Chang H, Wachtman LM, Pearson CB, Lee JS, Lee HR, et al. (2009) Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog 5: e1000606.
44. Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, et al. (2011) Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 92: 2272-2280.
45. Harberts E, Yao K, Wohler JE, Maric D, Ohayon J, et al. (2011) Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc Natl Acad Sci U S A 108: 13734-13739.
46. Donati D, Martinelli E, Cassiani-Ingoni R, Ahlqvist J, Hou J, et al. (2005) Variant-specific tropism of human herpesvirus 6 in human astrocytes. J Virol 79: 9439-9448.
47. Nitsche A, Muller CW, Radonic A, Landt O, Ellerbrok H, et al. (2001) Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183: 130-133.
48. Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, et al. (2008) Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J Immunol 180: 1326-1337.
49. Yao K, Gagnon S, Akhyani N, Williams E, Fotheringham J, et al. (2008) Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. PLoS ONE 3: e2028.
50. Kap YS, Jagessar SA, van Driel N, Blezer E, Bauer J, et al. (2011) Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 6: 341-353.
51. Harberts E, Yao K, Wohler J, Maric D, Ohayon J, et al. (2011) Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. PNAS 108: 13734-13739.
52. Levy JA, Ferro F, Greenspan D, Lennette ET, (1990) Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 335: 1047-1050.
53. Chen T, Hudnall SD, (2006) Anatomical mapping of human herpesvirus reservoirs of infection. Mod Pathol 19: 726-737.
54. Yalcin S, Mukai T, Kondo K, Ami Y, Okawa T, et al. (1992) Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. J Gen Virol 73 (Pt 7):: 1673-1677.
55. He J, McCarthy M, Zhou Y, Chandran B, Wood C, (1996) Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70: 1296-1300.
56. Ahlqvist J, Donati D, Martinelli E, Akhyani N, Hou J, et al. (2006) Complete replication cycle and acquisition of tegument in nucleus of human herpesvirus 6A in astrocytes and in T-cells. J Med Virol 78: 1542-1553.
57. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, et al. (1998) The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 4: 486-494.
58. Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hahn A, et al. (2005) Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J Neurovirol 11: 384-394.
59. De Filippis L, Foglieni C, Silva S, Vescovi AL, Lusso P, et al. (2006) Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. J Clin Virol 37 Suppl 1: S27-32.
60. Rouiller EM, Babalian A, Kazennikov O, Moret V, Yu XH, et al. (1994) Transcallosal connections of the distal forelimb representations of the primary and supplementary motor cortical areas in macaque monkeys. Exp Brain Res 102: 227-243.
61. Mori I, Nishiyama Y, Yokochi T, Kimura Y, (2005) Olfactory transmission of neurotropic viruses. J Neurovirol 11: 129-137.
62. Fotheringham J, Akhyani N, Vortmeyer A, Donati D, Williams E, et al. (2007) Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 195: 450-454.
63. Fujinami RS, von Herrath MG, Christen U, Whitton JL, (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19: 80-94.
64. Yamada M, Zurbriggen A, Fujinami RS, (1990) Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med 171: 1893-1907.